Katherine E. Talcott, MD
Show Description +
Dr. Talcott provides a look at the ultra-widefield retinal leakage assessment in patients with diabetic retinopathy after treatment with OTX-TKI (Ocular Therapeutix), an axitinib hydrogel, in the phase 1 HELIOS trial.
Posted: 8/06/2025
Katherine E. Talcott, MD
Dr. Talcott provides a look at the ultra-widefield retinal leakage assessment in patients with diabetic retinopathy after treatment with OTX-TKI (Ocular Therapeutix), an axitinib hydrogel, in the phase 1 HELIOS trial.
Posted: 8/06/2025
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2025.
Please log in to leave a comment.